Group One Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-615,700
| Closed | -$1.4M | – | 7551 |
|
|
2024
Q2 | $1.4M | Buy |
615,700
+73,000
| +13% | +$279K | 0.01% | 1728 |
|
|
2024
Q1 | $2.34M | Buy |
542,700
+265,500
| +96% | +$925K | 0.01% | 1372 |
|
|
2023
Q4 | $845K | Buy |
277,200
+240,200
| +649% | +$451K | ﹤0.01% | 2613 |
|
|
2023
Q3 | $53.3K | Sell |
37,000
-9,200
| -20% | -$17.8K | ﹤0.01% | 5040 |
|
|
2023
Q2 | $115K | Buy |
46,200
+6,000
| +15% | +$16.4K | ﹤0.01% | 4477 |
|
|
2023
Q1 | $108K | Buy |
40,200
+28,100
| +232% | +$135K | ﹤0.01% | 4254 |
|
|
2022
Q4 | $65.7K | Sell |
12,100
-100
| -0.8% | -$838 | ﹤0.01% | 4794 |
|
|
2022
Q3 | $152K | Sell |
12,200
-31,000
| -72% | -$354K | ﹤0.01% | 4401 |
|
|
2022
Q2 | $213K | Buy |
43,200
+12,900
| +43% | +$71.4K | ﹤0.01% | 4255 |
|
|
2022
Q1 | $230K | Sell |
30,300
-4,200
| -12% | -$39.8K | ﹤0.01% | 4653 |
|
|
2021
Q4 | $352K | Sell |
34,500
-26,400
| -43% | -$336K | ﹤0.01% | 4508 |
|
|
2021
Q3 | $817K | Sell |
60,900
-45,300
| -43% | -$738K | ﹤0.01% | 3633 |
|
|
2021
Q2 | $2.33M | Buy |
106,200
+2,600
| +3% | +$57.8K | ﹤0.01% | 2475 |
|
|
2021
Q1 | $2.49M | Buy |
103,600
+89,500
| +635% | +$2.08M | ﹤0.01% | 2222 |
|
|
2020
Q4 | $254K | Buy |
+14,100
| New | +$211K | ﹤0.01% | 3880 |
|
Group One Trading's GTHX Position: Q2 2024 in Review
Group One Trading sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 228,910 shares — an estimated $874K sold.
Group One Trading first reported a position in GTHX in Q4 2019 and held it in 12 quarters. The position peaked at $1.59M in Q4 2023. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.
- Group One Trading reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 228,910 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $874K.
- Group One Trading first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
- Group One Trading's G1 Therapeutics, Inc. Common Stock position peaked at $1.59M in Q4 2023.
- 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.